242 related articles for article (PubMed ID: 31451499)
1.
Albano M; Karau MJ; Greenwood-Quaintance KE; Osmon DR; Oravec CP; Berry DJ; Abdel MP; Patel R
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451499
[TBL] [Abstract][Full Text] [Related]
2.
Albano M; Karau MJ; Greenwood-Quaintance KE; Osmon DR; Oravec CP; Berry DJ; Abdel MP; Patel R
Microbiol Spectr; 2021 Sep; 9(1):e0007121. PubMed ID: 34259553
[TBL] [Abstract][Full Text] [Related]
3. Rifamycin resistance, rpoB gene mutation and clinical outcomes of Staphylococcus species isolates from prosthetic joint infections in Republic of Korea.
Lee Y; Kim SS; Choi SM; Bae CJ; Oh TH; Kim SE; Kim UJ; Kang SJ; Jung SI; Park KH
J Glob Antimicrob Resist; 2022 Mar; 28():43-48. PubMed ID: 34920175
[TBL] [Abstract][Full Text] [Related]
4. Rifampin, Rifapentine, and Rifabutin Are Active against Intracellular Periprosthetic Joint Infection-Associated Staphylococcus epidermidis.
Fisher C; Patel R
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33199387
[No Abstract] [Full Text] [Related]
5. Novel Use of Rifabutin and Rifapentine to Treat Methicillin-Resistant Staphylococcus aureus in a Rat Model of Foreign Body Osteomyelitis.
Karau MJ; Schmidt-Malan SM; Albano M; Mandrekar JN; Rivera CG; Osmon DR; Oravec CP; Berry DJ; Abdel MP; Patel R
J Infect Dis; 2020 Oct; 222(9):1498-1504. PubMed ID: 32914837
[TBL] [Abstract][Full Text] [Related]
6. Planktonic and Biofilm Activity of Eravacycline against Staphylococci Isolated from Periprosthetic Joint Infections.
Zhuchenko G; Schmidt-Malan S; Patel R
Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32988818
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of TNP-2092 against periprosthetic joint infection-associated staphylococci.
Fisher CR; Schmidt-Malan SM; Ma Z; Yuan Y; He S; Patel R
Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115040. PubMed ID: 32354459
[TBL] [Abstract][Full Text] [Related]
8. Large variations in clinical antibiotic activity against Staphylococcus aureus biofilms of periprosthetic joint infection isolates.
Mandell JB; Orr S; Koch J; Nourie B; Ma D; Bonar DD; Shah N; Urish KL
J Orthop Res; 2019 Jul; 37(7):1604-1609. PubMed ID: 30919513
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of tedizolid against staphylococci isolated from prosthetic joint infections.
Schmidt-Malan SM; Greenwood Quaintance KE; Karau MJ; Patel R
Diagn Microbiol Infect Dis; 2016 May; 85(1):77-9. PubMed ID: 26906190
[TBL] [Abstract][Full Text] [Related]
10. Rifabutin versus rifampicin bactericidal and antibiofilm activities against clinical strains of Staphylococcus spp. isolated from bone and joint infections.
Thill P; Robineau O; Roosen G; Patoz P; Gachet B; Lafon-Desmurs B; Tetart M; Nadji S; Senneville E; Blondiaux N
J Antimicrob Chemother; 2022 Mar; 77(4):1036-1040. PubMed ID: 35028671
[TBL] [Abstract][Full Text] [Related]
11. Genomics of Staphylococcus aureus and Staphylococcus epidermidis from Periprosthetic Joint Infections and Correlation to Clinical Outcome.
Trobos M; Firdaus R; Svensson Malchau K; Tillander J; Arnellos D; Rolfson O; Thomsen P; Lasa I
Microbiol Spectr; 2022 Aug; 10(4):e0218121. PubMed ID: 35762769
[TBL] [Abstract][Full Text] [Related]
12. Antibiofilm and intraosteoblastic activities of rifamycins against Staphylococcus aureus: promising in vitro profile of rifabutin.
Abad L; Josse J; Tasse J; Lustig S; Ferry T; Diot A; Laurent F; Valour F
J Antimicrob Chemother; 2020 Jun; 75(6):1466-1473. PubMed ID: 32125419
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant Staphylococcus epidermidis biofilms.
Yan Q; Karau MJ; Raval YS; Patel R
Int J Antimicrob Agents; 2018 Nov; 52(5):608-615. PubMed ID: 30048689
[TBL] [Abstract][Full Text] [Related]
14. Phage Activity against Planktonic and Biofilm Staphylococcus aureus Periprosthetic Joint Infection Isolates.
Totten KMC; Patel R
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0187921. PubMed ID: 34662191
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections.
Fernández J; Greenwood-Quaintance KE; Patel R
Diagn Microbiol Infect Dis; 2016 Aug; 85(4):449-51. PubMed ID: 27241369
[TBL] [Abstract][Full Text] [Related]
16. Optimizing combination rifampin therapy for staphylococcal osteoarticular infections.
Coiffier G; Albert JD; Arvieux C; Guggenbuhl P
Joint Bone Spine; 2013 Jan; 80(1):11-7. PubMed ID: 23332140
[TBL] [Abstract][Full Text] [Related]
17. Rifampin Resistance in Staphylococci after Rifaximin Intake for Surgical Prophylaxis in Elective Colorectal Surgery.
Padilla E; Oms L; Espejo E; Gómez L; Pagespetit L; Boada N; Bella F; Pérez J
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249689
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections, with focus on doxycycline.
Hamad T; Hellmark B; Nilsdotter-Augustinsson Å; Söderquist B
APMIS; 2015 Dec; 123(12):1055-60. PubMed ID: 26547372
[TBL] [Abstract][Full Text] [Related]
19. Rifaximin intake leads to emergence of rifampin-resistant staphylococci.
Valentin T; Leitner E; Rohn A; Zollner-Schwetz I; Hoenigl M; Salzer HJ; Krause R
J Infect; 2011 Jan; 62(1):34-8. PubMed ID: 21073894
[TBL] [Abstract][Full Text] [Related]
20. Role of Rifampin against Staphylococcal Biofilm Infections
Zimmerli W; Sendi P
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
